LAURUSLABSPharmaceuticals
Laurus Labs Ltd — Cash Flow Statement
₹992.70
-1.44%
Laurus Labs Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Short Term Debt Issuance | 323.91 Cr | 393.88 Cr | 84.95 Cr | 23.97 Cr | — |
| Net Long Term Debt Issuance | -136.84 Cr | 147.17 Cr | 136.67 Cr | 246.27 Cr | — |
| Long Term Debt Payments | -315.70 Cr | -216.69 Cr | -246.83 Cr | -167.77 Cr | — |
| Long Term Debt Issuance | 178.86 Cr | 363.86 Cr | 383.50 Cr | 414.04 Cr | — |
| Investing Cash Flow | -681.72 Cr | -822.42 Cr | -996.06 Cr | -914.34 Cr | — |
| Net Other Investing Changes | -41.39 Cr | -0.40 Cr | 9.17 Cr | -11.74 Cr | — |
| Interest Received Cfi | 6.15 Cr | 5.61 Cr | 4.56 Cr | 1.72 Cr | — |
| Net Investment Purchase And Sale | -41.39 Cr | -0.40 Cr | 9.17 Cr | — | -0.16 Cr |
| Net Business Purchase And Sale | -105.35 Cr | -151.62 Cr | -22.30 Cr | -27.60 Cr | — |
| Purchase Of Business | -105.35 Cr | -151.62 Cr | -22.30 Cr | -27.60 Cr | — |
| Net PPE Purchase And Sale | -541.13 Cr | -676.01 Cr | -987.49 Cr | -876.72 Cr | — |
| Sale Of PPE | 99.87 Cr | 2.30 Cr | 2.67 Cr | 0.12 Cr | — |
| Purchase Of PPE | -641.00 Cr | -678.31 Cr | -990.16 Cr | -876.84 Cr | — |
| Operating Cash Flow | 601.65 Cr | 665.69 Cr | 993.90 Cr | 911.10 Cr | — |
| Taxes Refund Paid | -137.54 Cr | -104.57 Cr | -285.49 Cr | -182.27 Cr | — |
| Change In Working Capital | -374.60 Cr | -29.02 Cr | -315.26 Cr | -341.61 Cr | — |
| Change In Other Current Liabilities | 266.17 Cr | -88.52 Cr | -10.30 Cr | 201.26 Cr | — |
| Change In Other Current Assets | -54.96 Cr | -38.50 Cr | 9.94 Cr | -15.75 Cr | — |
| Change In Payable | -97.99 Cr | 334.41 Cr | -168.87 Cr | -301.21 Cr | — |
| Change In Inventory | -82.86 Cr | -151.31 Cr | 81.83 Cr | -174.33 Cr | — |
| Change In Receivables | -404.96 Cr | -85.10 Cr | -227.86 Cr | -51.58 Cr | — |
| Other Non Cash Items | 194.79 Cr | 169.39 Cr | 140.91 Cr | 84.47 Cr | — |
| Stock Based Compensation | 10.23 Cr | 10.92 Cr | 7.48 Cr | 6.64 Cr | — |
| Provisionand Write Offof Assets | 53.36 Cr | 4.92 Cr | 0.61 Cr | -0.49 Cr | — |
| Depreciation And Amortization | 430.09 Cr | 384.58 Cr | 324.08 Cr | 251.49 Cr | — |
| Depreciation | 430.09 Cr | 384.58 Cr | 324.08 Cr | 251.49 Cr | — |
| Net Foreign Currency Exchange Gain Loss | -1.92 Cr | -8.82 Cr | 12.42 Cr | 7.81 Cr | — |
| Gain Loss On Sale Of PPE | -57.05 Cr | 1.93 Cr | 0.21 Cr | 1.21 Cr | — |
| Net Income From Continuing Operations | 484.29 Cr | 236.36 Cr | 1.11K Cr | 1.08K Cr | — |
| Free Cash Flow | -39.35 Cr | -12.62 Cr | 3.74 Cr | 34.26 Cr | — |
| Repayment Of Debt | -315.70 Cr | -216.69 Cr | -246.83 Cr | -167.77 Cr | — |
| Issuance Of Debt | 502.77 Cr | 757.74 Cr | 468.45 Cr | 438.01 Cr | — |
| Issuance Of Capital Stock | 10.17 Cr | 2.56 Cr | 7.44 Cr | 4.31 Cr | — |
| Capital Expenditure | -641.00 Cr | -678.31 Cr | -990.16 Cr | -876.84 Cr | — |
| End Cash Position | 99.54 Cr | 138.94 Cr | 45.67 Cr | 75.35 Cr | — |
| Beginning Cash Position | 138.94 Cr | 45.67 Cr | 75.35 Cr | 48.46 Cr | — |
| Effect Of Exchange Rate Changes | 1.39 Cr | 0.17 Cr | -0.88 Cr | -0.13 Cr | — |
| Changes In Cash | -40.79 Cr | 93.10 Cr | -28.80 Cr | 27.02 Cr | — |
| Financing Cash Flow | 39.28 Cr | 249.83 Cr | -26.64 Cr | 30.26 Cr | — |
| Net Other Financing Charges | 125.32 Cr | — | — | — | — |
| Interest Paid Cff | -209.22 Cr | -174.31 Cr | -140.40 Cr | -85.00 Cr | — |
| Cash Dividends Paid | -43.13 Cr | -86.18 Cr | -107.47 Cr | -85.86 Cr | — |
| Net Common Stock Issuance | 10.17 Cr | 2.56 Cr | 7.44 Cr | 4.31 Cr | — |
| Common Stock Issuance | 10.17 Cr | 2.56 Cr | 7.44 Cr | 4.31 Cr | — |
| Net Issuance Payments Of Debt | 187.07 Cr | 541.05 Cr | 221.62 Cr | 270.24 Cr | — |
| Net Short Term Debt Issuance | 323.91 Cr | 393.88 Cr | 84.95 Cr | 23.97 Cr | — |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Laurus Labs Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.